| Patents for C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079) |
|---|
| 07/07/2010 | CN101772481A Substituted alditol compounds, compositions, and methods |
| 06/23/2010 | EP2199295A1 Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome |
| 06/23/2010 | EP2199290A2 Method of nucleating a polyolefin composition with acetal-based compounds |
| 06/22/2010 | US7741352 for the treatment or alleviation of pain, headaches, nervous system disorders or trauma, stroke, neurodegenerative diseases, cardiovascular disorders, inflammatory diseases, vision defects, hearing disorders, respiratory system disordres and urinary incontinence |
| 06/22/2010 | CA2297198C Macrocyclic lactones, compositions, and methods of use |
| 06/17/2010 | US20100152098 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof |
| 06/16/2010 | CN1889949B PDK-1/Akt signaling inhibitors |
| 06/15/2010 | US7737152 6-carboaryl-oxy-pyrazin-2-yl-carboaryl-amines and compositions comprising said compounds |
| 05/26/2010 | EP2189442A1 Process and intermediates for the preparation of aliskiren |
| 05/26/2010 | EP1747213B1 Novel 7,7-disubstituted derivatives of (5h,9h)-6,8-dioxabenzocycloheptene, preparation method thereof and use of same in the synthesis of non-steroidal vitamin d analogues |
| 05/19/2010 | CN101103036B Artemisine (Qinghaosu) derivatives, their preparation methods and their use, and pharmaceutical compositions containing the same |
| 05/18/2010 | CA2382465C Compositions and methods for modulating apoptosis in cells over-expressing bcl-2 family member proteins |
| 05/12/2010 | CN1556699B Process for isolating phenolic compounds |
| 05/05/2010 | CN101701233A Application of yingluo mycin in preparing drug resisting plant pathogenic fungi |
| 04/27/2010 | US7704752 Reacting sample with boronate-coumarin derivatives and mesuring color, absorbance, fluorescence, chemiluminescence, and/or bioluminescence |
| 04/15/2010 | WO2010042867A2 Activators of human pyruvate kinase |
| 04/15/2010 | CA2740148A1 Activators of human pyruvate kinase |
| 04/14/2010 | EP2173733A2 Compositions and methods comprising analogues of radicicol a |
| 04/13/2010 | US7696361 Chemical reagents capable of selective attachment to and reaction with peptides and proteins |
| 04/06/2010 | CA2319807C Novel antifungal compound and process for producing the same |
| 03/30/2010 | US7687635 Metal complexes useful in metathesis and other reactions |
| 03/09/2010 | US7674921 cloprostenol or latanoprost; topical use; highly crystalline structures that are easy to formulate into ophthalmic solutions; hydrolysis of these analogs releases only the active PGF2 alpha analog free acid, without the production of toxic and irritant small aliphatic alcohol coproducts |
| 03/04/2010 | US20100055800 Compositions for Chemiluminescent Detection of Hydrogen Peroxide |
| 02/25/2010 | US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 02/18/2010 | US20100041619 Lasonolide compounds as reagents for inducing premature chromosome condensation and methods for treating disorders |
| 02/02/2010 | US7655429 biological conjugate drug; used in immunodiagnostic assays to compete with topiramate for anti-topiramate antibodies; competitive bonding; finding the right dosage of anti-epileptic drug for each patient |
| 12/30/2009 | WO2009139811A3 Chemiluminescent methods and reagents for analyte detection |
| 12/30/2009 | CN100575350C Macrocyclic glyceride with oxidization resistant activity and its preparation method and use |
| 12/29/2009 | US7638291 biological conjugate drug; used in immunodiagnostic assays to compete with topiramate for anti-topiramate antibodies; competitive bonding; finding the right dosage of anti-epileptic drug for each patient |
| 12/22/2009 | US7635742 Modified isocyanates |
| 12/17/2009 | US20090312392 Amino ceramide-like compounds and therapeutic methods of use |
| 12/16/2009 | EP1928854B1 Chiral compounds |
| 12/09/2009 | EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 12/09/2009 | EP1112274B1 Chemiluminescent 1,2-dioxetanes |
| 12/09/2009 | CN100567271C Improved purification of 4,4'(5')-di-t-butylcyclohexano-18-crown-6 |
| 12/02/2009 | CN101591228A Novel azulene compounds and application thereof |
| 11/24/2009 | CA2157917C Improved enhancement of chemiluminescent assays |
| 11/18/2009 | EP1421071B1 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators |
| 11/04/2009 | EP1641465B1 Combinations of an aryl aniline beta-2 adrenergic receptor agonist and a corticosteroid |
| 10/20/2009 | US7605111 Herbicides |
| 10/08/2009 | US20090253908 Novel m3 muscarinic acetylchoine receptor antagonists |
| 10/08/2009 | US20090253701 such as (2S,4S,5S,7S)-5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (2-phenoxy-ethyl)-amide, having renin-inhibiting properties, used for the treatment of hypertension, cardiovascular, vision, neurodegenerative, kidney and liver disorders |
| 10/07/2009 | CN101550128A Axial chirality diamine compound induced by central chirality and synthetic method |
| 10/01/2009 | WO2009120191A1 Process for the preparation of benzo-fused heteroaryl sulfamates and crystalline form of n- ( ( (2s) -6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methyl-sulfamide |
| 10/01/2009 | US20090247616 Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety |
| 10/01/2009 | CA2719624A1 Process for the preparation of benzo-fused heteroaryl sulfamates and crystalline form of n- ( ( (2s) -6-chloro-2,3-dihydro-1,4-benzodioxin-2-yl) methyl-sulfamide |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/15/2009 | CA2218699C 1,3-propane diol derivatives as bioactive compounds |
| 09/08/2009 | US7585889 cloprostenol or latanoprost; topical use; highly crystalline structures that are easy to formulate into ophthalmic solutions; hydrolysis of these analogs does not have toxic and irritant small aliphatic alcohol coproducts; hypotensive agent for intraocular pressure |
| 09/01/2009 | US7582765 Aryl aniline β2 adrenergic receptor agonists |
| 08/26/2009 | EP2091934A1 Ketomethionine ketals and their derivatives |
| 08/13/2009 | US20090203770 COMPOSITIONS AND METHODS FOR MODULATING APOPTOSIS IN CELLS OVER-EXPRESSING Bcl-2 FAMILY MEMBER PROTEINS |
| 08/05/2009 | CN101497596A Method for synthesizing diethyleno dioxide |
| 07/30/2009 | US20090192122 Inflammatory cytokine release inhibitor |
| 07/16/2009 | WO2009089450A1 Synthesis of macrocyclic cancer chemotherapy agents and methods of use |
| 07/16/2009 | WO2009089210A1 Preparation of sulfamide derivatives |
| 07/16/2009 | CA2711466A1 Process for the preparation of sulfamide derivatives |
| 07/07/2009 | US7557176 Polyhydroxyalkanoic acid having vinyl, ester, carboxyl or sulfonic acid group and producing method therefor |
| 06/30/2009 | US7553979 Heat Shock Protein 90 inhibitors; e.g. breast cancer, prostate cancer |
| 06/30/2009 | US7553971 Aryl aniline β2 adrenergic receptor agonists |
| 06/04/2009 | WO2007110415A3 Use of diacetyl trimers and cosmetic or therapeutic formulations containing these compounds |
| 05/28/2009 | US20090137660 Cytokine Modulators Using Cyclic Glycerides of Essential Polyunsaturated Fatty Acids |
| 05/27/2009 | CN100491336C Novel derivatives of 3,3-diphenylpropylamines |
| 05/20/2009 | DE102007055124A1 New 7-(3-methylbut-2-en-1-yl)-2H-1,5-benzodioxepin-3(4H)-one, useful as fragrance and/or flavor material, and in e.g. shampoo, softener, detergent, pre-shave product, floor cleaner, air freshener and sunscreen cream |
| 05/13/2009 | CN101429188A Synthesis of watermelon ketone |
| 04/30/2009 | US20090111183 Ketone Ligands for Modulating the Expression of Exogenous Genes Via An Ecdysone Receptor Complex |
| 04/29/2009 | EP1446379B1 Aryl aniline beta-2 adrenergic receptor agonists |
| 04/28/2009 | US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis |
| 04/22/2009 | EP1585757A4 Peptide deformylase inhibitors |
| 04/21/2009 | US7521414 Polyene-polyol structure; anticancer agents |
| 04/16/2009 | US20090099252 Novel laulimalide analogues as therapeutic agents |
| 04/15/2009 | EP2048140A1 Deuterated chemiluminescent 1,2-dioxetanes |
| 04/14/2009 | CA2182325C Di-substituted 1,2-dioxetane compounds having increased water solubility and assay compositions |
| 04/02/2009 | WO2005039500A3 METHOD FOR THE PRODUCTION OF BIOACTIVE SUBSTANCES FROM THE NOVEL ACTINOMYCETE TAXON MAR2 (“Marinophilus”) |
| 04/01/2009 | CN101397289A Method for preparing 2-isopropyl-1,3-dioxo-5-cyclohepten |
| 03/26/2009 | US20090082426 Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof |
| 03/24/2009 | US7507817 Glaucome therapy; vision defects |
| 03/18/2009 | EP1689380A4 Method for treating adamts-5-associated disease |
| 03/17/2009 | US7504425 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 03/12/2009 | WO2008149244A3 Compositions and methods comprising analogues of radicicol a |
| 03/05/2009 | US20090062284 Thio-Substituted Biarylmethanesulfinyl Derivatives |
| 02/26/2009 | WO2009025728A1 Substituted alditol compounds, compositions, and methods |
| 02/12/2009 | US20090042981 FDA Orange book listed patent for fesoterodine fumarate; urinary incontinence; isobutyric acid 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenyl ester is fesoteridine |
| 02/12/2009 | US20090041669 Light-Emitting Biomarker |
| 02/03/2009 | US7485736 Process for producing α-methylstyrene |
| 01/21/2009 | EP2015745A2 Macrocyclic kinase inhibitors |
| 01/21/2009 | CN101347508A Effective component of Sinomenium acutum and preparation and use thereof |
| 01/15/2009 | US20090018116 Therapeutic Compounds |
| 01/13/2009 | US7476647 1,5-dioxa-3-methyl-16-cyclohexadecanone; original odor characteristics, diffuses extremely well and is suitable for use as a fragrance, for example in cosmetic preparations, technical products or in alcoholic perfumery. |
| 01/07/2009 | EP1687291A4 Novel cyclic oxygenated compounds having cooling, fragrance, and flavor properties, and uses thereof |
| 12/25/2008 | US20080318956 Inflammatory cytokine release inhibitor |
| 12/24/2008 | DE102008024867A1 Preparing dihydro-6H-dioxa-binaphthalenyl-cyclononenol, useful to prepare crystalline substance that is useful to prepare chiral dopants for liquid crystalline mixtures, comprises reacting bi-2-naphthol with substituted epoxy compounds |
| 12/24/2008 | CN101328165A Macrolides spice 1,10-dicarboxydecane propylene phthalate and production method thereof |
| 12/23/2008 | US7468437 useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P; treatment of certain disorders, including emesis, depression, and anxiety |
| 12/18/2008 | US20080311113 Method for treating adamts-5-associated disease |
| 12/17/2008 | CN101323608A Process for synthesis of cyclic BINOL derivatives |
| 12/04/2008 | WO2008144982A1 Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome |
| 12/04/2008 | US20080300298 Honokiol Derivates For the Treatment of Proliferative Disorders |
| 12/04/2008 | CA2688495A1 Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome |
| 12/03/2008 | EP0984000B1 Process for producing amide derivatives and intermediate compounds |